jardiance a glp 1 Jardiance® A Comprehensive Comparison of Metformin
Description
Biochem Res Int
Fractyl submitted its first Clinical Trial Application in Europe in May 2025
Biotechs are obvious investment candidates, although they can prove to be a binary outcome, and pharmaceutical companies are obvious for public market investors
It is not a diagnosis or prediction
It is reflected in mortality data showing that cardiovascular disease is a leading cause of death in SLE, particularly in patients who survive the first five years after diagnosis
